Kerala Ayurveda targets ₹200 cr revenue by FY27
The nano-cap firm aims for 38% growth, banking on a 130% surge in e-products and a path to operating breakeven by January 2027.
What's new
- Management targets ₹200 cr revenue for FY27.
- Operating breakeven is set for January 2027.
- Standalone revenue crossed ₹100 cr for the first time in FY26.
Why this matters
The guidance is ambitious for a company with a market cap of ₹275 cr. Achieving this target would mean generating revenue equivalent to 73% of its current market valuation, making the execution of its e-product and health services strategy the primary test for investors.
What we're watching
- Progress on the delayed capital funding closure.
- Quarterly updates on the 130% e-product growth target.
- Cost-control measures as the company nears the January 2027 breakeven goal.
The full read
Kerala Ayurveda is setting a high bar for its ₹275 crore market cap. Management has issued FY27 revenue guidance of ₹200 crore, a 38% jump over the ₹145.4 crore reported in FY26. The company is betting on a 130% surge in its global e-product business and a 45% expansion in health services to get there. It also plans to hit operating breakeven by January 2027. While the standalone business recently crossed the ₹100 crore revenue threshold for the first time, the scale of this new target is significant—it represents roughly 73% of the company's current total market value. A delay in capital funding closure adds a layer of friction to these plans. Investors now have a concrete framework to track, but the gap between current operations and the ₹200 crore target is wide. The next few quarters will determine if this growth is realistic or merely aspirational.
Questions answered
- What is the primary driver behind the FY27 revenue target?
- The company expects growth to come from a 130% expansion in its global e-product business and a 45% increase in health services.
- How does the FY27 guidance compare to recent performance?
- The company reported total revenue of ₹145.4 cr in FY26, with standalone revenue crossing the ₹100 cr mark for the first time.
- When does Kerala Ayurveda expect to reach operating breakeven?
- The company targets operating breakeven by January 2027, relying on revenue scale-up and cost-reduction measures.
- Are there any risks to the current growth plan?
- The filing notes a delay in the closure of capital funding, which remains a key variable for the company's financial trajectory.